Laura Bender
Impact in
-
- Phytochemicals and Medicinal Plants
- Medicinal Plants and Neuroprotection
-
- Glioma Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Oncology 15
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Adam I. Marcus (5 shared papers)R. Donald Harvey (3 shared papers)Thota Ganesh (3 shared papers)Paula M. Vertino (2 shared papers)Jose Thaiparambil (3 shared papers)Anapatricia García (2 shared papers)Erik R. Kline (3 shared papers)Mourad Tighiouart (2 shared papers)
- Journals
- Cancers (3 papers)Cancer Research (2 papers)Annals of Translational Medicine (2 papers)Journal of Cachexia Sarcopenia and Muscle (2 papers)Cancer (1 paper)
- Partner nations
- FranceUnited StatesTürkiye
In The Last Decade
Laura Bender
27 papers receiving 441 citations
Peers
Comparison fields: 5 of 66
- Complementary and alternative medicine 137
- Genetics 42
- Oncology 105
- Cancer Research 43
- Biomaterials 37
Countries citing papers authored by Laura Bender
This map shows the geographic impact of Laura Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bender more than expected).
Fields of papers citing papers by Laura Bender
This network shows the impact of papers produced by Laura Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bender. The network helps show where Laura Bender may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Bender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 225 | |
| 2 | 2014 | 65 | |
| 3 | 2022 | 27 | |
| 4 | 2020 | 21 | |
| 5 | 2019 | 16 | |
| 6 | 2011 | 13 | |
| 7 | 2019 | 11 | |
| 8 | 2021 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2022 | 2 | |
| 18 | 2024 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2020 | 2 |
About Laura Bender
Laura Bender is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Epidemiology, having authored 33 papers that have together received 451 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Breast Cancer Treatment Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Meningioma and schwannoma management (4 papers), Glioma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Phytochemicals and Medicinal Plants (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Complementary and alternative medicine (137 citations), Genetics (42 citations), Oncology (105 citations), Cancer Research (43 citations) and Biomaterials (37 citations). Laura Bender has collaborated with scholars based in France, United States and Türkiye. Frequent co-authors include Adam I. Marcus, R. Donald Harvey, Thota Ganesh, Paula M. Vertino, Jose Thaiparambil, Anapatricia García, Erik R. Kline, Mourad Tighiouart, Yuan Liu and Izzie Jacques Namer. Their work appears in journals such as Cancers, Cancer Research, Annals of Translational Medicine, Journal of Cachexia Sarcopenia and Muscle and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.